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Abstract
Focused ultrasound (FUS) has been proposed for a variety of minimally invasive thera-
peutic applications, including tumor ablation, neuromodulation, targeted drug delivery
and blood brain barrier opening. To date, FUS beams have been primarily monitored
through MR and ultrasound diagnostic imaging modalities. The recent introduction of
real-time dual-mode ultrasound array (DMUA) systems offers a new paradigm for the
guidance of therapeutic focused ultrasound. The DMUA approach allows for inherent
registration between the therapeutic and imaging coordinate systems.
In this thesis we investigated the use of ultrasound-based thermography to assess FUS-
tissue interactions. Specifically, we focused on two aspects of image-guided therapy:
1) monitoring and localization of FUS-tissue interactions, and 2) tissue damage assess-
ment. Towards this end, we presented first experimental results of ultrasound-guided
transcranial FUS in a rat brain, both ex vivo and in vivo. DMUA imaging was used
to monitor and localize FUS-tissue thermal interactions in real-time. The transcranial
echo data allowed for a reliable estimation of temperature change in brain tissue, which
had never been done before using ultrasound image guidance. Despite some measurable
distortion and loss in focusing gain, transcranial FUS beams at 3.2 MHz were localized
axially and laterally. This confirms the results obtained using DMUA-based transcra-
nial ultrasound thermography. A high degree of focusing with the DMUA was then
successfully leveraged to perform localized tissue damage assessment in both ex vivo
and in vivo. The experimental results presented in this thesis demonstrate some of the
unique aspects of image guidance using DMUAs, especially when FUS is subject to
significant distortions as in transcranial applications.
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Chapter 1
Introduction
1.1 Focused Ultrasound: Historical Overview
In the 1950s focused ultrasound (FUS) was extensively investigated by the Fry broth-
ers at the Biophysical Research Laboratory, established at the University of Illinois.
William and Francis Fry designed a complex system consisting of a multi-beam ir-
radiator [1–3], allowing placement of trackless lesions measuring cubic millimeters in
volume [4]. The custom-built system was used for a first comprehensive study on fo-
cused ultrasound effects in the central nervous system of in vivo animals [5]. The study
revealed FUS ability to create reversible [5–7] and irreversible [1, 2, 5, 8] changes; the
study also reported ultrasonic dosage curves for the brain as a function of intensity and
time [5]. The Fry brothers supplemented their findings with a thorough histological
examination, which revealed differential response of white matter compared to grey, in
addition to preservation of blood vessels [5]. The extensive studies conducted in vivo
brain structures in cats and monkeys [1–3, 5, 8], prepared the Fry brothers for a col-
laboration with Dr. Russell Meyers, Chief of Neurosurgery at the University of Iowa
School of Medicine, to treat patients with Parkinsons disease [4]. Although successful
results were demonstrated in nearly 50 patients [4], the widespread use of FUS therapy
did not occur due to a seemingly better alternative medication – L-dopa [9]. Follow-
up studies on a number of FUS-treated patients, 20+ years post treatment, revealed
1
2no adverse effects in untargeted brain locations – confirming sparing of tissues located
prefocally [4].
The remarkable results demonstrated by the Fry brothers, both in animals and human
patients, were achieved without monitoring. The ability to target deep seated anatom-
ical structures was possible through anatomical atlas referencing, where the skull was
carefully placed inside the holder with ear bars, in addition to infra-orbital and oral
clamps. Afterwards, the position was deduced by referring to a published anatomical
atlas with coordinates. To achieve greater confidence in targeting, X-ray imaging was
done to confirm internal landmarks [4]. Due to a lack of monitoring, much conjecture
existed in the physical basis of ultrasound (US) effects on biological media.
Prior to the 1970s, the mechanism of FUS tissue destruction was largely attributed
to mechanical effects of the beam [10]. In 1973, Lele and Pierce [11] emphasized the
importance of heat generation during lesion formation process, as a result they proposed
thermal hypothesis of the mechanism of ultrasonic focal destruction. The hypothesis
found that for low acoustic power and short duration exposures, the diameter of the
lesion was correlated to the temperature history at the lesion site [10]. Subsequently,
a model was derived to predict cellular damage from the temporal temperature profile
[10].
Lele also examined the role of cavitation during lesion formation in a fresh calf liver [10].
In this study a 2.7MHz source was used to generate 0.2 second and 0.3 second bursts of
FUS. Monitoring was performed with a 50 µm thermocouple and a wide-band receiver,
which recorded acoustic emissions during FUS bursts. The outcome of the study was
identification of three distinct intensity regions, with unique heating and acoustic emis-
sion profiles: 1) intensity region < 500 W/cm2 exhibited a predictable temperature rise
without presence of acoustic emissions, 2) intensity region between 500 W/cm2 and 1000
W/cm2 revealed a higher than expected temperature rise and a subharmonic emission
(stable cavitation), 3) intensity region > 1000 W/cm2 displayed a dramatic increase in
temperature and aharmonic emission (collapsed cavitation) in addition to subharmonic
emission. These results demonstrate the first correlation between presence of cavitation
and enhanced heating. The potential of controlled cavitation to facilitate a faster and
a more effective FUS treatment was later proposed by Holt and Roy [12].
3Monitoring of beam interaction with tissue led to important discoveries on focused ultra-
sound effects on biological media. Visualization of acoustic emissions with a wide-band
receiver allowed Lele to identify intensity regions with unique acoustic signatures. The
first two regions were deemed safe for FUS therapeutic applications, and the third re-
gion was pronounced unsafe, as collapsed cavitation could lead to uncontrollable internal
hemorrhage and metastases [10]. Lele’s work demonstrated that a thorough understand-
ing of FUS effects on tissue was realized through monitoring of the FUS beam.
1.2 FUS Monitoring Modalities
MRI and ultrasound are currently the most widely used modalities for image guidance,
both clinically and in research laboratories. These two methods are reviewed in [13].
Advantages of MR-guided focused ultrasound (MRIgFUS) include high soft tissue con-
trast, high spatial resolution, real-time temperature monitoring [14], and elastography
monitoring [15]. The limitations of MRIgFUS monitoring are the high cost, and slow
monitoring update rates on the order of 1 second [16].
Ultrasound, on the other hand, is less expensive, portable, and offers high-frame rate
updates to the operator in the form of echogenicity changes on B-mode images [17,18].
Additional ultrasound-guided focused ultrasound (USgFUS) capabilities, researched in
the laboratory setting, offer highly localized quantitative tissue property maps in the
form of temperature [19–23], elastography [24–28], vibroacoustography [29], and passive
cavitation detection [10, 30, 31]. The major limitation of ultrasound is poor soft tissue
contrast.
MRIgFUS and USgFUS systems use two separate modalities for FUS delivery and
therapy monitoring. As a result, there are limitations on the therapeutic protocols
imposed by the source of monitoring. For example, Sonavelle MR-HIFU system (Philips
Healthcare, Helsinki, Finland) is limited by the slow temperature update rate (every
2.9 seconds) and a relatively poor temperature spatial resolution (2.5mm x 2.5mm) [32].
These limitations pose restrictions on the fibroid tumor size eligible for treatment [32].
They also result in long treatment procedures that can last more than 4 hours [32].
Ultrasound, unlike MRI, offers faster update rates, which are suitable for moving organs.
4However, the form of feedback is limited to echogenic changes, which is indicative of
boiling and/or cavitation presence and not purely thermal damage. There is a growing
need for a dynamic monitoring modality, capable of motion compensation, obstacle
visualization, and highly localized tissue property mapping.
1.3 DMUA: Brief Overview
At the beginning of this century a new paradigm was introduced to the field of focused
ultrasound – Dual-Mode Ultrasound Array (DMUA). DMUA offers inherent registration
of imaging and therapy planes, as it is uses the same elements for both purposes [33].
The common practice in the field had been to mechanically integrate a commercially
available probe with the therapeutic transducer; prior to 1998 no one had attempted
use of therapeutic arrays as a monitoring modality. Simon et al. [23] demonstrated use
of DMUAs for monitoring applications in tissue-mimicking phantoms.
The design and construction of a therapeutic array emphasize the therapeutic efficacy of
the prototype [33,34]. Characteristics of a therapeutic transducer are determined by the
depth and the size of the acoustical window available [33]. To optimize heating rate at
a specific depth, the array is designed with a relatively low operating frequency and the
array (focusing) gain is maximized, resulting in a low f-number [33]. To achieve desired
power at the target, the number of elements is minimized and efficiency is maximized,
producing relatively large directive elements. These array characteristics – low operating
frequency, low f-number, large directive elements – are common to therapeutic arrays.
Unfortunately, they also introduce two limitations for imaging applications. First is a
limited field of view, and second is a reduced dynamic range (observed if grating lobes
are present due to very directive elements) [34]. Additional limitation, which had com-
promised imaging quality of therapeutic arrays, was rooted in material properties of the
commonly used piezoceramic transducers. Piezoceramic transducers exhibited lateral
cross-coupling between elements, which degraded imaging and therapeutic performance
of the transducer. The cross-coupling problem was solved with the introduction of
piezocomposite material [35]. An additional advantage of piezocomposite material is it
allows fabrication of a highly concave transducer (low f-number) [35].
5The difficulties associated with imaging by therapeutic transducers did not prevent
the research community from demonstrating DMUA’s major advantages. The first
two advantages are high spatial resolution along with co-registration of imaging and
therapy planes; both of these characteristics allow for imaging feedback with a high
degree of sensitivity and specificity to the tissue changes at the focus. As a result,
DMUA can be used for real-time monitoring of cavitation and/or boiling [33,36] at the
focus. Furthermore, DMUA offers a robust closed-loop control capable of addressing
motion compensation [37] and tissue property-based adaptive lesion formation [38]. A
third advantage of DMUA is the ability of DMUA to image interaction of the beam with
the target region. This functionality is extremely valuable in the presence of obstacles
(e.g. ribs), as was demonstrated in [39,40] for treatment of liver cancer.
The intricacies of DMUA system and imaging modes will be further discussed in Chapter
2.
1.4 My Contributions
The main contribution of this dissertation is the assessment of FUS-tissue interactions
using a DMUA with emphasis on thermal interactions. Detailed characterization of
DMUA transcranial imaging was performed ex vivo in a Sprague Dawley rat, focusing
on degradation of imaging resolution, loss of focusing gain, and ability to recognize
anatomical landmarks. First, imaging performance was characterized through visual-
ization of a wire target phantom, which captured point spread function of the array.
Second, focusing gain was evaluated with a transcranial heating experiment and a ther-
mocouple. Third, a comparative anatomy study was conducted to capture the same rat
head with two modalities: DMUA and MRI.
The feasibility and safety of DMUA-guided brain therapies were demonstrated in vivo
rodent model, where STF-based thermography provided feedback indicative of tissue
interrogated with FUS in 8+ animals. An effort was made to further characterize
temperature profiles observed in vivo, through careful assessment of DMUA focus dis-
tortions due to propagation through rat skulls (extracted from in vivo animals). The
characterization study involved two complementary experiments. The first experiment
6was designed to estimate the amount of energy transmitted through the rat skull and
optimal transmission frequency. The experimental setup included two single-element
transducers facing each other and a skull positioned in the middle. The second experi-
ment enabled visualization of DMUA focus distortion through the skull at two different
frequencies. DMUA focus mapping was done in axial-lateral and lateral-elevation pro-
files utilizing a hydrophone.
The DMUA’s ability to interrogate tissue in a very small volume was demonstrated
experimentally. This functionality could be extremely valuable for characterization of
tissue before and after lesion formation. To evaluate tissue properties an interrogation
shot, also known as a subtherapeutic shot, was delivered. The shot typically lasts 1
second or less and results in a temperature increase of a few degrees (1-3◦C). There
is no thermal damage resulting from subtherapeutic exposure, making it an ideal can-
didate for tissue probing. The temperature profile captured from the subtherapeutic
shot was used to extract the initial heating rate (indicative of tissue absorption) from
US thermography data collected before and after lesion formation in vivo rat. Further,
computed thermography maps were registered atop lesions captured in gross photogra-
phy. The merit of this method to access damaged tissue was also validated in a number
of ex vivo bovine tissue samples.
1.5 Organization of This Thesis
Chapters in this thesis were organized as follows:
• Chapter 2 introduces the DMUA system, in addition to synthetic aperture and sin-
gle transmit focus imaging, along with the algorithm for US-based thermography
calculation.
• Chapter 3 provides characterization of transcranial synthetic aperture and STF-
based thermography with DMUA.
• Chapter 4 discusses feasibility of guidance, monitoring and FUS delivery in vivo
setting, in addition to ex vivo lesion formation.
7• Chapter 5 characterizes DMUA focus through the skull, and aims to explain ob-
servations made in the previous chapter.
• Chapter 6 introduces quantitative parameter mapping based on ultrasound ther-
mography data with a commercial US scanner both ex vivo and in vivo.
• Chapter 7 draws conclusions from the research findings and discusses future di-
rection.
Chapter 2
DMUA System and Temperature
Imaging
2.1 Image-guided Focused Ultrasound
The experiments presented in this thesis utilized either a DMUA integrated with a
diagnostic ultrasound scanner or a full DMUA systems. Both systems are described in
greater detail in this section.
2.1.1 Integrated Image Guidance Using DMUA and Diagnostic Ultra-
sound
Lesion formation and monitoring for the initial experiments was performed using a
3.5MHz DMUA integrated with a Sonix RP ultrasound (US) scanner (Ultrasonix,
British Columbia, Canada). Figure 2.1(a) illustrates how the DMUA center opening
accommodated HST15-8/20 probe connected to SonixRP. The HST15-8/20 probe had
a 10 MHz center frequency and a 12 mm elevation focus. The characteristics of this
probe resulted in an axially localized point spread function (axial resolution = 0.3 mm,
lateral resolution = 2.4 mm) [36].
The DMUA utilizes a piezocomposite technology [41] and was manufactured by Imasonic
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9(Voray sur l’Ognon, France). The array had 64 elements, 1.3 mm in width X 6.8 mm in
height, arranged in two rows on a spherical cross-section with a radius of 40 mm. The
hole was positioned between two rows of elements and measured 16.5 mm in height.
The inter-element spacing between each element was 0.2 mm. The element size is an
important factor for the array, and will determine the therapeutic operating field. The
therapeutic operating field is the region around the geometric focus where the focusing
gain is within -3 dB of the maximum focusing gain at the DMUA geometric center. For
the fenestrated DMUA the theraputic operating field extended ±5 mm axially and ±5
mm laterally from (x, z) = (0 mm, 40 mm).
The alignment of DMUA with HST15-8/20 enabled a co-axial registration between
therapy and imaging plane, allowing for optimal visualization of tissue changes at the
focus. As described in [42], the RF data acquisition from the Sonix RP and DMUA is
performed at a high frame rate, allowing the tracking of tissue deformation in response to
subtherapeutic HIFU beams. Subtherapeutic energy deposition raises the temperature
only on the order of 1-3◦C, resulting in no observable thermal damage at the focus.
Monitoring tissue response to subtherapeutic FUS (at the lesion location) before and
after lesion formation may provide a means of measuring quantitative changes in tissue
property in response to tissue damage, e.g. tissue absorption and tissue diffusivity.
2.1.2 DMUA System
The majority of the experimental results presented in this thesis were collected with a
full DMUA depicted in Figure 2.1(b). The array had 64 elements, 1.3mm in width X 14.5
mm in height, arranged in two rows on a spherical cross-section with a radius of 40 mm.
The inter-element spacing between each element was 0.2 mm. The therapeutic operating
field was defined at -3 dB and extended ±2.5 mm axially and ±3 mm laterally from
the geometric center. During imaging and therapy applications DMUA was operated at
3.2 MHz. The control architecture for imaging and therapy was custom designed and is
documented in greater detail by D. Liu and E. Ebbini [42] and Casper et al. [36].
The console depicted in Figure 2.2, illustrates the render interface available to the
operator during imaging and therapy with a full 3.5MHz DMUA. The image (A) is an
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(a) Fenestrated 3.5MHz DMUA
(b) Full 3.5MHz DMUA
Figure 2.1: Dual-Mode Ultrasound Arrays
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SA image, with the temperature overlaid at a preselected region of interest (ROI). The
imaging field of view (the region around the geometric focus where SA imaging produces
spatially accurate, high-contrast maps of the object) extended ±10 mm and ±8 mm
from the geometric center in the axial and lateral dimensions, respectively. Images
(B), (C), and (D) represent axial-temporal, axial-lateral, and lateral-temporal cross-
sections through the temperature profile. By examining each cross-section a localized
heating spot is visualized at 40.5 mm axially and 2 mm laterally. Based on the temporal
behaviour of the shot, pictured in (E), it is evident that the duration of the shot is 1
second long, with exponential heating response starting at 1 second and stopping at 2
seconds. The desktop console also allows the operator to define imaging and therapy
parameters, for example imaging center frequency, focal depth, amplitude and duration
of the desired exposure.
2.1.3 DMUA Imaging Modes
Synthetic Aperture Imaging
Synthetic aperture imaging is an imaging mode that synthesizes transmit and receive
focus at every pixel in the image. This process results in a maximum sensitivity image.
To form an SA image, a 32 element array would transmit 32 consecutive pulses and
capture resulting echoes after each transmission. Both the full and fenestrated array
had 64-elements, but upper and lower element rows were coupled, reducing the number
of transmissions to 32. Equation 2.1 describes the image formation process for SA,
I(xp, zp) =
Ne∑
i=1
Ne∑
j=1
Ai ·Bj · si,j
(
Rip +Rjp
c
)
·D(θi) ·D(θj) (2.1)
where Ne is the number of elements, Ai and Bi are the transmit and receive apodization
weights, si,j is the echo received on element j when transmitting with element i, Rip
and Rjp are respective distances from the transmit and receive elements to the image
pixel P, D(θi) and D(θj) are the transmit and receive elements directivity weighting
functions [33].
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Figure 2.2: DMUA System User Console
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According to equation 2.1, low resolution images reconstructed for every transmit-
receive element combination were summed to form an SA image. The total number
of images summed was 32 X 32 = 1024. As a result of this summation process, the
resolution and SNR were significantly improved. To further improve image quality the
directivity matrix was incorporated, it suppressed signal from low SNR regions and sup-
pressed grating lobes due to coarse aperture sampling [33,34]. The directivity weighting
function is described by the equation 2.2,
D(θ) =
sin[kd sin(θ)/2]
kd sin(θ)/2
(2.2)
where k = 2pi/λ, d is element width, and θ is an angle between vector from element to
geometric center and vector from element to pixel P [33].
Synthetic aperture imaging mode was utilized extensively throughout this thesis. An
example of an SA image of a 50 µm wire at the focus is depicted in Figure 2.3(a).
The wire is localized at (x,z) = (0mm, 40mm) and appears more elongated in the axial
dimension, which is consistent with the point spread function of the array. Currently,
the DMUA system designed in our laboratory allows simultaneous therapy and SA
monitoring at a frame rate of ≈ 30fps. During in vivo experiments SA imaging allowed
to localize therapeutic plane through the skull of the rat, enabling visualization of skull
cross-section and cheek muscles. SA imaging was also used to inspect lesions for presence
of cavitation and/or boiling [33].
Single-Transmit Focus Imaging
Single-transmit focus imaging is an imaging mode, where a focused transmit beam is
used to form a 2D image. To form an STF image a 32-element array would transmit a
single focused wave on all of the elements and capture the resulting echoes. Equation
2.3 describes the STF image formation process:
I(xp, zp) =
Ne∑
j=1
Bj · sj
(
R0 +Rjp
c
)
(2.3)
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(a) Synthetic Aperture Image
(b) ingle-Transmit Focus Image
Figure 2.3: Exaples of an SA and STF images
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where sj(t) is the echo received on element j due to the tramsmitted beam and R0 is a
fixed distance to the focus of the transmit beam. The rest of the variables are similar
to those presented for the SA image formation [33].
Equation 2.3 is a simplified version of the equation 2.1, depicting only one sum. This
resulted due to the change in the transmit sequence. As a result of this change, there
arose two advantages for imaging with STF. First advantage is the ability to visualize
obstacles on the path of the beam. A successful STF-based refocusing was demonstrated
in the presence of Plexiglas ribs [40]. This application has the potential to enable a more
robust liver ablation therapy around the ribs [40]. The second advantage of STF imaging
is the speed of feedback, which can easily reach 1000 frames/second. Fast update
rates allows for real-time monitoring during ablation procedures, allowing operator to
visualize tissue-specific changes and tissue motion on the order of milliseconds [36]. The
main disadvantage of STF imaging is its limited lateral resolution. An example of STF
image of a 50 µm wire is depicted in Figure 2.3(b). The wire is located at (x,z) = (0mm,
40mm), however it is no longer localized in the lateral dimension.
Spatial Resolution
Two methods were used to estimate spatial resolution of the imaging modality. The
first method is based on imaging through a cross-section of a wire phantom, as seen
in Figure 2.3(a). Axial and lateral traces are then plotted through the maxima of the
wire, and resolution values are estimated based on a 6-dB cutoff. The second method
is derived from a uniform region of the target. To estimate axial and lateral resolution,
a correlation based approach was used. Equations 2.4 and 2.5 describe computation of
the axial (Scx) and lateral (Scz) cell size:
Scx =
∫ −X
X
CI(x, 0)
CI(0, 0)
dx (2.4) Scz =
∫ −Z
Z
CI(0, z)
CI(0, 0)
dx (2.5)
where CI(x,z) is a 2D autocovariance function.
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2.2 Ultrasound Thermography
In the mid-1990’s two research groups, Seip et al. [19,20,43] and Moreno et al. [21,22,44],
independently proposed a noninvasive method for monitoring temperature during FUS
treatments. The proposed method relied on two, temperature dependent, phenomena:
speed of sound and tissue expansion [20,44]. The first variable, speed of sound, increases
linearly with temperature during small changes in temperature (< 10◦C) [22, 45, 46].
The second variable, tissue expansion, also exhibits a liner change in the presence of
highly focused ultrasound beam [20, 44]. The change in the speed of sound result in
an apparent shift in the RF-data; the change in tissue expansion lead to a physical
shift of the RF-data. Thus, in order to estimate temperature, echo shifts are computed
first.
2.2.1 Displacement Computation
To compute echo shifts between two consecutive frames a 2D complex autocorrelation
method was used, previously described by Simon et al. [23]. During the computation two
dimensions were considered, axial (z) and lateral (x). There are four key steps involved
in estimation of the incremental time time-shift. The first step, described by equation
2.6, computes convolution between discrete-time sampled RF-echo data, r(m,n,s) and
an FIR Hilbert Transform, h(m):
r˘(m,n, s) = r(m,n, s) ∗ h(m) (2.6)
The second step is to compute analytic signal, as seen in equation 2.7:
rˆ(m,n, s) = r(m,n, s)− jr˘(m,n, s) (2.7)
The fourth step computes the q-th lag along the axial dimension, where an observation
window M X N is chosen in the axial and lateral dimensions respectively,
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γˆ(m,n, ; q, 0) =
M
2
−1∑
m′=−M
2
N
2
−1∑
n′=−N
2
rˆ(m+m′, n+n′, s−1) · rˆ∗(m+m′+q, n+n′, s−1) (2.8)
where ∗ represents complex conjugation.
The final step is to compute incremental time-shifts from the phase of the autocorrela-
tion function at lags q=-1, q=0 and q=1 according to the equation:
δtˆ(m,n) =
2∠γˆ(m,n, ; 0, 0)
∠γˆ(m,n, ; 1, 0)− ∠γˆ(m,n, ;−1, 0) tsp (2.9)
where ∠ is the angle symbol. For a more thorough discussion of the algorithm please
refer to [23].
2.2.2 Temperature Computation
After infinitesimal displacement was computed, temperature was estimated according
to a recently proposed differentiator-integrator filter by Bayat et al. [37]. Equation 2.10
illustrates an IIR filter which performed recursive differentiation and integration of the
echo shifts.
4˘θ = −2
ατ + Ts(α+ β)
1− z−1
1− ατ−Ts(α+β)ατ+Ts(α+β)z−1
δ˘τ (2.10)
where 4˘θ and δ˘τ are z transforms of 4θ and δτ , Ts is sampling time of the RF-data,
α is linear coefficient of thermal expansion, β represents thermal dependence of speed
of sound in tissue, and τ=2z0/c.
The model upon which the filter was derived builds upon Simons et al. [23] paper. Major
differences in the new derivation are: 1) accounting for non-uniform baseline tempera-
ture; and 2) reduction of spatial temperature variations as well as artifacts.
Figure 2.4(a) depicts an axial-temporal temperature profile through the center of the
DMUA focus. In the figure positive and negative temperatures are alternating, starting
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from 35mm and extending to ≈ 41 mm. Two most prominent heating locations were
present at (z) = 38.8 mm and (z) = 40.1 mm, their representative temporal curves are
visualized in Figure 2.4(c). The temporal response for both locations revealed almost
identical exponential heating and decay profiles with the exception of a negative sign.
In 1998 Simon et al. suggested use of a threshold-based approach to eliminate negative
temperatures, where only positive temperatures were displayed. Temperature profiles
presented in this thesis follow threshold-based approach, and display temperatures only
above 0◦C as seen in Figure 2.4(b).
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(a) Temperature (Positive & Negative) (b) Temperature (Negative)
(c) Temperature Traces
Figure 2.4: STF-based Thermography
Chapter 3
Characterization of Transcranial
Imaging with DMUA
3.1 Introduction
The dual-mode ultrasound array (DMUA) is a new paradigm in the field of focused ultra-
sound, offering the user full capabilities of a standalone therapeutic platform. We have
designed and begun an experimental validation study of a DMUA system for forming,
monitoring, and characterizing subtherapeutic pulsed transcranial focused ultrasound
(tFUS) fields in an ex vivo rat model. In this chapter, we present ex vivo results that
demonstrate the capabilities of a DMUA to place image-guided tFUS beams as well as
monitor their interactions with brain tissue. The results shown provide experimental
validation of the ability of DMUA imaging to capture important landmarks to allow the
targeting of specific regions within the brain. In addition, we present experimental re-
sults demonstrating the effectiveness of DMUA-based, real-time transcranial ultrasound
thermography (UST) to monitor and localize the thermal response to subtherapeutic
applications of tFUS. The UST estimates were validated using thermocouple measure-
ments in ex vivo experiments.
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3.2 Methods
3.2.1 DMUA System
The 3.5 MHz DMUA described in Section 2.1 was used to perform transcranial therapy
imaging and therapy in the rat model. The DMUA was operated in two imaging modes:
synthetic aperture (SA) and single transmit focus imaging (STF). SA imaging was used
for the guidance of transcranial focused ultrasound (tFUS) treatment. STF imaging
was used to calculate thermography estimates and monitor the lesion formation process.
Both SA and STF images were beamformed with the speed of sound at 1520 m/s. The
results are detailed in this chapter.
Calibration of Subtherapeutic FUS Output
As the thermal effects of ultrasound are largely dependent on acoustic power, an ul-
trasound power meter was used to calibrate the acoustic output of the DMUA. To
determine how various driving voltages correlated to acoustic output, individual sub-
therapy exposures were calibrated with an ultrasound power meter (Ohmic Instruments,
Easton, MD, USA). Consequently, a subset of subtherapeutic exposures was identified:
0.25, 0.56, 1.0, 1.26, 2.25, 4.0, 6.25, and 9 Watts (acoustic). Acoustic power can be
further translated into focal intensity by taking into account the gain of the array and
its surface area (11.46 cm2). Final FUS focal intensities ranged from 100 W/cm2 for
the 0.25 W exposure to 3500 W/cm2 for the 9W exposure.
3.2.2 Visualization of Anatomical Landmarks with the DMUA
To guide transcranial treatment with the DMUA, it was necessary to identify anatomical
features on the SA images. The characterization of anatomical features involved imaging
the head from a sacrificed rat with two modalities: ultrasound (DMUA) and MRI. A
3D volume of SA images was acquired by moving a 3D servomotor stage in 1 mm
increments, spanning 21 mm in length starting at the eyes and moving towards the ears
of the rat. The MRI volume was acquired with a 9.4 Tesla scanner and a quadrature
22
(a) Five wires inserted in the brain tissue
(b) Brain positioned in front of DMUA
Figure 3.1: Experimental setup for determination of spatial resolution with SA imaging.
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coil. The voxel resolution of the collected MRI images measured 117 µm × 117 µm ×
234 µm in the axial, lateral, and elevation dimensions, respectively.
3.2.3 Spatial Resolution of Synthetic Aperture DMUA Imaging
To characterize the imaging resolution of the synthetic aperture imaging through the
skull, a wire resolution test was performed. In preparation for wire insertion, the skull
was transected with a bone saw (Mar-Med Inc., Cleveland, OH, USA) through the
coronal plane at two locations, caudal with respect to the eyes and rostral with respect
to the ears, isolating the middle of the brain. Transecting the skull allowed easy access
to the brain for the insertion of five 50 µm wires. As seen in Figure 3.1(a), five individual
wires were carefully inserted with the help of forceps. Afterwards, the skull was secured
to a rubber holder and positioned for imaging with the DMUA, as seen in Figure 3.1(b).
To estimate the lateral and axial resolution, all five wires were individually aligned
with the geometric center of the array (x, z ) = (0, 40)mm. The lateral and axial
traces through the wire centers were subsequently examined and resolution values were
computed based on a -6dB cutoff criterion.
3.2.4 Power Calibration with a Thermocouple
To further calibrate power exposure, we collected thermocouple (T/C) measurements
for a subset of subtherapeutic and therapeutic exposures. A 200 µm T-type copper-
constantan thermocouple (Omega, Stamford, CT) was inserted in the brain, as seen in
Figure 3.1(b). The shaft of the thermocouple was perpendicular to the imaging plane,
which allowed for a direct visualization of the T/C cross-section on the SA image. Using
transcranial FUS and a 3D servomotor stage, the thermocouple junction was localized,
and two subsequent tests were performed:
1. Profiling the tFUS Beam: Six 1-second tFUS shots were generated at the geometric
center (x, z) = (0, 40)mm. The shots were delivered with the T/C and the brain
at six different locations around the intended focus (200 µm between locations).
This test measured how sharply the heating rate dropped in the vicinity of the
target point (in both axial and lateral dimensions).
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2. Bracketing the tFUS Heating Rate: The T/C was positioned in the vicinity of
the tFUS focal spot to minimize the viscous heating while maintaining the sensi-
tivity to the local heating. A 1-second exposure was conducted for five different
power settings at the same focal location. STF imaging frames were collected
synchronously with T/C measurements for each shot. Ultrasound thermography
was used to estimate the temperature change at the expected tFUS focal spot for
each exposure. This test served to compare the sensitivity of DMUA-based UST
to thermocouple measurements as well as providing a calibration for expected
temperature rise during planned in vivo experiments where T/C measurements
could not be used.
3.2.5 Transskull Lesion Formation Ex Vivo
Focused ultrasound therapy was delivered in sacrificed normal rats with no prior FUS
treatment. After the sacrifice, the head of the animal was separated from the body and
secured to a motorized stage, similar to the setup depicted in Figure 3.1(b) except the
skull was not transected with a saw. Using SA imaging guidance the therapeutic FUS
lesions were placed 6-8 mm below the skin in the left hemisphere of the animal brain. The
right hemisphere of the brain served as a control upon histological examination.
There were a total of three varying exposure levels and time durations: 36 W for 1
second, 49 W for 1 second and 64 W for 0.6 seconds (respective power values were
extrapolated from subtherapeutic doses; skull attenuation was not taken into account).
For each exposure and time combination three shots were conducted, resulting in a total
of nine insonications. During the lesion formation procedure, monitoring was performed
with STF imaging (with the imaging plane parallel to the coronal plane) and was carried
out before, during and after shot delivery with a frame rate of 400 fps.
Upon completion of the experiment, the brain was extracted, formalin-fixed and paraffin
embedded. A histotechnologist obtained axial sections through the animal brain at 300
µm intervals. The axial plane of the animal brain coincided with the elevation plane of
the transducer. Sectioned cross-sections were stained with hematoxylin and eosin stain
and submitted for detailed examination by a certified neuropathologist.
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(a) MRI: Plane 1 (b) SA: Plane 1
(c) MRI: Plane 2 (d) SA: Plane 2
(e) MRI: Plane 3 (f) SA: Plane 3
Figure 3.2: MRI and SA (55 dB) cross-sections of three representative planes.
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3.3 Results
3.3.1 Anatomical Correspondences: MRI and DMUA
Figure 3.2 shows MRI (left) and SA (right) images from the same animal. The compar-
ison revealed several anatomical landmarks on the MRI scan that were also apparent
in the SA images. The dorsal aspect of the skull was clearly visualized, capturing the
frontal, parietal, interparietal and occipital bones. The floor of the cranial cavity and
cheek muscles shown in the MRI were also clearly outlined in the SA images. Identifying
anatomical landmarks through feature visualization on registered MRI and SA images,
supports the use of DMUA as a therapy guidance modality for small rodents.
3.3.2 Spatial Resolution of Synthetic Aperture DMUA Imaging
A synthetic aperture image containing five 50 µm wires is depicted in Figure 3.3(a).
Five individual SA acquisitions were used to produce this c-scan image, and with each
capture the geometric focus was closely aligned with the location of a wire. The lateral
axis on the image was aligned with the middle wire, located at 0 mm and the outermost
wire segments located at -5 mm and 5 mm. In the axial dimension the echoes for all
wires were located at ≈40 mm. The fourth wire from the left has a unique echo, which
can be attributed to a slight bend introduced upon its insertion.
Axial and lateral traces through the middle wire are also seen in Figure 3.3(b) and
Figure 3.3(c), respectively. When examining the axial profile of the middle wire, the
reflection from the skull appears first at about ≈32 mm and its amplitude was set to
0 dB, and the wire was localized at 40 mm axially and -10 dB in amplitude. In the
lateral profile, Figure 3.3(c), the wire presented a peak at 0 mm. The resolution values
were evaluated at -6 dB and correspond to 440 µm and 560 µm in the axial and lateral
dimensions respectively. Similar values were computed for each inserted wire, and are
summarized in Table 3.1.
The summarized results give further evidence that DMUA has the ability to visualize
structures through the brain with sub-mm accuracy in the lateral and axial dimensions.
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(a) Synthetic-aperture image of brain cross-section
(b) Axial trace through the center wire (c) Lateral trace through the center wire
Figure 3.3: Results of transcranial PSF measurement.
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The wire echoes appeared minimally distorted through the bone and are in close agree-
ment with estimates obtained in a water setting. The variation in the resolution values
for each individual wire segment can be explained by their varying position within the
skull.
Table 3.1: Spatial Resolution of a 50 µm Wire Embedded within Brain Tissue
Resolution L1 L2 L3 L4 L5
Axial (µm) 440 510 480 340 440
Lateral (µm) 560 640 553 462 495
3.3.3 Characterization of the Transcranial FUS Heating Focus and
the Calibration of DMUA Thermography
To characterize DMUA focal heating, a T/C was inserted perpendicular to the imaging
beam of the array. With the guidance of synthetic aperture imaging, the tip of the
T/C was visualized in Figure 3.4(a). Colored dots depicted in the figure represent six
targeted locations, spaced 0.2 mm apart, where an FUS shot was delivered with a power
of 4 W and exposure of 1 second. Temperatures recorded at each of the locations were
plotted in Figure 3.4(b). The temperature curves revealed a sharp drop in temperature
outside of a narrow lateral band, as seen in the orange and yellow lines. Temperatures
recorded along the axial dimension exhibited a less pronounced change in the heating
rate, due to the longer beam length along the axial axis. The dark blue dot was observed
to have the largest increase in temperature, indicating it was the closest to the T/C
junction.
After calibrating the DMUA spatially, the acoustic power of the DMUA was calibrated
in relation to the temperature change in the T/C at one location. The location closest
to the T/C junction, represented by the blue dot, was chosen during this calibration
step. At this location five subtherapeutic shots (0.25 W, 1 W, 2.25 W, 4 W, and 6.25
W) were delivered with duration of 1 second.
Figure 3.4(c) shows the T/C temperature before, during and after exposure for each
shot. Figure 3.4(d) shows the change in temperature occurring with each shot based on
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(a) Six spatial heating locations close to the ther-
mocouple.
(b) Thermocouple temperature for locations in (a).
(c) Thermocouple temperature (d) STF-based UST
Figure 3.4: DMUA tFUS subtherapy with thermocouple calibration: (a) Six spatial
heating locations around the thermocouple junction (0.2 mm spacing), (b) recorded
temperatures for the six locations seen in (a), (c) STF-based UST and (d) thermocouple
measurements recorded at the dark blue dot in (a). Legends are representative of
ultrasound power levels in water measured in Watts.
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the STF thermography, with the ∆T axis set to match the amplitude of thermocouple
estimates. The major difference between the temperatures acquired through the T/C
and those acquired through STF thermography was that for the thermocouple measure-
ments, during the FUS ON phase, the temperature curves approximated an exponential
change function and for the STF thermography the curves resembled a linear function.
In contrast, during the cooling phase both T/C and STF thermography revealed expo-
nential decay functions. This effect was most likely due to the close proximity of the
T/C to the tracking region, thus introducing an artifact. The exponential rise of the
temperatures was more pronounced when the T/C was removed.
3.3.4 Transskull Lesion Formation Ex Vivo
Figure 3.5(a) shows an example of a lesion formed in the left hemisphere with a 1 second
tFUS exposure at an acoustic power of 49 W (power was linearly extrapolated based on
low power measurements; nonlinear wave interaction was not taken into account). The
cells were thermally coagulated, and a sharp transition was observed between coagulated
and normal tissue. A more detailed depiction of the lesion is seen in Figure 3.5(b),
where the perimeter of the lesion was outlined with a red marker. The diameter of
the lesion cross-section was measured at 689 µm. The lesion was visualized in two
axial histological slices, thus the height of the lesion was between 600 µm and 900 µm.
The control region captured in Figure 3.5(c) did not reveal presence of coagulated or
compromised cells.
Additional shots were conducted, but only one lesion was observed on the histology. This
one documented result demonstrates the high degree of transcranial focusing possible
with the DMUA beam.
3.3.5 Conclusion
The feasibility of real-time image-guided placement and monitoring of tFUS beams us-
ing dual-mode ultrasound arrays was demonstrated in an ex vivo rat model. Synthetic
aperture DMUA imaging was shown to reliably capture key anatomical features delin-
eating the scalp, the skull and the base of the skull. Subtherapeutic lesion formation
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(a) Full Section (0.4X)
(b) Lesion (10X) (c) Control (10X)
Figure 3.5: Thermal lesion formed in the left hemisphere of the rat brain.
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with DMUA in the vicinity of a thermocouple validated the high degree of spatial focus-
ing possible with the DMUA. These findings were further validated during histological
examination of the DMUA formed lesions. The next chapter will build upon these
ex vivo results, and demonstrate real-time image-guided placement and monitoring of
subtherapeutic and therapeutic tFUS.
Chapter 4
In Vivo Real-Time Transcranial
Therapy and Ex Vivo Lesion
Formation with DMUA
4.1 Introduction
Building on the ex vivo work from Chapter 3, the experiments in this chapter demon-
strated the capabilities of a DMUA to deliver and monitor subtherapeutic and ther-
apeutic tFUS. First, subtherapeutic tFUS monitoring was tested in eight animals in
the presence of breathing and pulsation. After three days the animals were sacrificed
and the tissue was evaluated by a neuropathologist. Second, therapeutic tFUS was
performed ex vivo and tissue changes were monitored with the DMUA.
4.2 Methods
The in vivo therapy and monitoring was performed with a full 3.5 MHz DMUA system.
To establish a successful coupling of the DMUA to the head of the animal, the DMUA
was encapsulated inside a water bolus as seen in Figure 4.1(a), and a layer of ultrasound
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gel was applied to the surface of the bolus. The in vivo experiments in eight Sprague
Dawley rats were performed under the IACUC protocol (ID # 1403122A).
4.2.1 Temperature Imaging with DMUA (In Vivo)
At the start of the procedure, the animals were given an intramuscular injection of
9-10 mg of Ketamine and 1 mg per 275-299 g of body weight of Xylazine. After the
anaesthesia took effect, the head of the animal was shaved with Oster clippers (Philips,
Amsterdam, Netherlands); to remove remaining fine hair a thin layer of a depilatory
cream (Church & Dwight, Ewing, NJ, USA) was applied to the head.
For the remainder of the experiment the rats were anaesthetised with a Harvard Ap-
paratus (Harvard Apparatus, Holliston, MA, USA), which delivered a constant flow of
isoflourane and oxygen. Also, to ensure minimal movement of the head and minimize
the effects of breathing, the head was secured in a stereotaxic frame (World Precision
Instruments, Inc, Sarasota, FL, USA). Throughout the procedure a veterinary techni-
cian was responsible for monitoring the well-being of the animal, including breathing
rate and body temperature. For four out of eight animals, vital signs (ECG and body
temperature) were continuously monitored with a BIOPAC system (BIOPAC Systems,
Inc., California, USA).
The DMUA procedure started with identifying a location within the skull under the
guidance of synthetic aperture imaging. To ensure that the focal point of the transducer
was at least 5 mm under the skin surface, the cranium ceiling was positioned at 34+/-
2 mm and the cranium floor at 45+/-2 mm in the axial dimension.
During FUS delivery, locations of interest were identified under SA guidance. To mini-
mize movement, the array beam was often steered +/-2 mm in axial and lateral dimen-
sions. When axial adjustment of the therapeutic operating field was needed, the bolus
was either inflated or deflated to deposit energy at the desired location.
As in previous ex vivo experiments, the first step was to bracket energy delivery to five
(0.25 W, 1.00 W, 2.25 W, 4.00 W, and 6.25 W) subtherapeutic levels, and identify the
lowest level sufficient to visualize the temperature rise above the noise floor. Subsequent
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(a) DMUA encapsulated inside a water bolus.
(b) Rat fixed in stereotaxic U-frame for transcranial imaging with DMUA.
Figure 4.1: Transcranial DMUA imaging and subtherapeutic heating in vivo.
36
exposures were delivered at the pre-determined power level. The exposure duration was
kept constant for all experimental subjects at 1 second. A total of 38 locations were
interrogated with 2 minutes between shots in eight animals; in 66% of the interrogated
locations the FUS shot was delivered at least twice to test the repeatability of the
temperature measurement.
Histological Evaluation
The animals survived for a period of three days under the watchful observation of
veterinary technicians and a veterinary physician. The sacrifice was performed with
approximately 5 minutes of CO2 asphyxiation. Afterwards, in the first three animals
the tissue was immediately excised, fixed in formalin and processed. A histotechnologist
obtained hematoxylin and eosin stained sections at intervals of 300 µm. Slides were then
evaluated by a neuropathologist. For the remaining animals, the skull cap was isolated
and preserved in formalin for subsequent testing.
4.2.2 Lesion formation in Ex Vivo Rats
Lesion formation was tested in a sacrificed Sprague Dawley female rat. After, the
animal was sacrificed with CO2 asphyxiation it was weighed. The weight of the rat was
recorded at 256 grams and the animal head was prepared for the experiment. First, the
head was shaved with electric Norelco clippers (Philips, Stamford, CT) and afterwards
a depilatory cream was applied (Church & Dwight Co., Inc., Princeton, NJ). Second,
to ensure a secure attachment to the motor, the head was separated from the body.
To preserve the original position of the skin at the cut site, a layer of Loctite super
glue (Henkel Co., Westlake, OH) was used to secure it. The head was then pinned to a
rubber holder and secured to a 3-axis servomotor. The holder was then immersed inside
a degassed, deionized water bath at room temperature (T = 24◦C). Lesion formation
was performed in the left side on the animal’s brain; the right side served as a control
where no therapy or imaging was performed.
Lesions were delivered in a systematic manner. First, the occipital bone was localized
on the SA image. Figure 4.2(a) depicts the approximate location of the SA reference
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(a) Rat skull with the blue arrow depicting the approximate location of
the reference plane used to visualize the occipital bone.
(b) The anatomical structures (cerebellum, cerebrum, and olfactory bulb)
are visualized underneath the skull. The blue arrow depicts the approxi-
mate location of the reference plane used to visualize the occipital bone.
Figure 4.2: Visualization of landmarks for the transcranial lesion formation experiment.
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plane, and Figure 4.2(b) illustrates the cerebellum, cerebrum, and olfactory bulb’s posi-
tions underneath the skull. Both images were acquired from Rat Anatomy 3D software
(Biosphera, Saint Charles, Brazil). Second, the therapy plane was located by moving 3
mm in the rostral direction from the occipital bone. Third, three different power levels
(49 W, 64 W, 81 W) were tested with respective durations of 1.9 seconds, 1.1 seconds,
and 0.7 seconds.
As depicted in Figure 4.3 17 lesions were created:
• 6 lesions at 81 W for 0.7 seconds, represented by red X’s
• 6 lesions at 64 W for 1.1 seconds, represented by orange X’s
• 5 lesions at 49 W for 1.9 seconds, represented by yellow X’s
4.3 Results
4.3.1 DMUA Imaging and Subtherapy In Vivo
The in vivo experiments were carried out in eight female Sprague Dawley rats. The
figures presented here are from the first two rats (rat A and rat B), with the results from
rat A presented first. The cross-section of the targeted plane is seen in Figure 4.4(a), a
hyperechoic structure is present at ≈ 38 mm. The axes of the image are aligned with the
DMUA, where (x,z) = (0, 40)mm is the geometric focus of the array. The focal beam
of the array was steered to (x, z) = (-1, 42)mm, and a subset of subtherapeutic shots
were delivered, at five intensities: 0.25 W, 0.55 W, 1 W, 1.56 W, and 2.25 W.
The typical axial-temporal profile through the center focus is pictured in Figure 4.4(c).
Localized heating was observed at ≈38 mm, 4 mm above the intended focus and at
the location of the hyperechoic structure visualized on the SA image. The heating
response was consistent with FUS ON and FUS OFF times. About 2 mm below the
observed heating, evidence of a pulsating artery is seen, with a pulsation rate (180 beats
per minute) consistent with the typical heart rate of a rat. Figure 4.4(c) summarizes
temporal temperature traces at the location of the maximum temperature increase (≈38
mm axially). For the low energy doses, the temperature rise was within the noise floor
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Figure 4.3: Matrix of Lesions formed in a Sprague Dawley Rat.
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of the baseline; however, when a more distinctive ∆T was achieved at 1 W and higher,
the shots were repeated three times to estimate the variance and repeatability of tFUS
delivery and STF-based monitoring. The temperature traces reveal low variation for 1
W and 2.25 W, and more variability at 1.56 W.
In rat B, the therapy field is shown in Figure 4.4(b). Similar to rat A, a strong reflection
is observed at ≈38 mm. The focus was located at (x, z) = (-1, 40)mm and the axial-
temporal temperature profile is recorded in Figure 4.4(d). Shots were delivered at
two acoustic powers, 1 W and 1.56 W. The higher acoustic power produced a spatial
heating profile well above the baseline and as a result was repeated twice. The temporal
variability for a 1.56 W shot was small (see Figure 4.4(f)), and the spatial heating
response was very similar to the 1.56 W shot in rat A.
The results for the remaining 6 rats are not presented; however, the shots delivered
produced similar responses to the results observed in rats A and B.
In summary, the in vivo experiments tied in with the ex vivo results presented earlier.
Out of the 38 locations interrogated in eight animals, measurable temperature change
was observed in all 38 cases, i.e. a sensitivity of 100%. The specificity of the observed
response was 92%. In some cases, the peak temperature change was observed 2 mm
proximal to the target. During bracketed delivery of subtherapeutic shots, the heating
rate scaled linearly with delivered acoustic power. Repeatability of the temperature
with low variance was established. The heating rate also agreed with experimental
results presented earlier ex vivo.
In addition to localized temperature increases, the STF-based temperature imaging
algorithm also revealed the presence of pulsation in the targeted regions. Figures 4.6 (a)
and (c) depict strain data at a cross-section through the skull. The artery is located at
46 mm, and the respective arterial pulsation is evident on the trace seen in Figure 4.6(b).
The data was collected at 400 fps. Increasing the sampling rate to 1000 fps revealed
a more informative strain curve as seen in Figure 4.6(d), with evidence of a diastolic
notch observed in 4 out of 4 pulsation cycles.
To further validate visualization of pulsating structures, the DMUA was used to image
the heart. The animal was placed on its back, and the DMUA was centered on its
41
(a) Rat A: SA image (b) Rat B: SA image
(c) Rat A: axial-temporal temperature (d) Rat B: axial-temporal temperature
(e) Rat A: temperature (f) Rat B: temperature
Figure 4.4: Results for in vivo STF-based thermography in rats A and B.
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spinal column. Under the imaging guidance of the DMUA, the focus was positioned
in cross-section with the heart, and the presence of strong pulsation was seen at the
focus. The computed strain in Figure 4.6(f) resembles the strain common to a ventricle.
As with the transcranial experiments, the pulsation was estimated at 180 beats per
minute.
Safety and Efficacy of the In Vivo Treatment
Upon completion of the experiment all eight animals successfully recovered from the
anaesthetic. During a three day recovery period, no physiological or behavioral deficits
were observed. Also, ECG and body temperature data collected from the selected rats
confirmed no apparent deviation of the vital signs from the normal baseline. Subsequent
histological examination of tissue confirmed a lack of cellular damage and inflammation
markers. These observations served as evidence that tFUS delivery results in only a low
temperature rise. Therefore, shots delivered for 1 second in the range between 0.25-6.25
W are safe, even when repeated at 2 minute time intervals.
4.3.2 Lesion formation in Ex Vivo Rats
The objective of the transskull lesion formation experiment was to test transskull mon-
itoring with STF imaging and to identify the duration and acoustic power needed for
successful lesion formation. The objective was tested in a Sprague Dawley rat, where
consistent doses of tFUS were delivered at 17 locations. The highest exposure was cho-
sen as 81 W for a duration of 0.7 seconds; consecutive exposures are calculated to keep
the therapeutic dose constant through a relationship of C = I
√
t [47]. Only one of the
17 exposures created a clear lesion originating at the focus. The remaining 16 exposures
exhibited either an immediate or a delayed response at the surface, obscuring evidence
of change at the focal point. Figure 4.7 summarizes these results for three acoustic
powers, with two examples for each power level.
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Figure 4.5: Surface edema photographed after therapy completion. The ruler in the
photographs correspond to a millimeter scale.
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(a) Transskull: Temperature at 400 fps (b) Transskull: Strain trace of an artery
(c) Transskull: Temperature at 1000 fps (d) Transskull: Strain trace of an artery
(e) Heart: Temperature at 1000 fps (f) Heart: Strain trace of a ventricle
Figure 4.6: Pulsation data recorded in rat B, where transskull imaging was done for
(a), (b),(c) and (d); imaging of the heart was done in (e) and (f).
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(a) tFUS 49 W (b) tFUS 49 W
(c) tFUS 64 W (d) tFUS 64 W
(e) tFUS 81 W (f) tFUS 81 W
Figure 4.7: Lesion formation in a Sprague Dawley rat imaged with STF at three different
power levels.
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Figure 4.7(d) presents a clear example of the lesion formation process starting at the fo-
cal point, ≈40 mm axially, and growing toward the surface. This was the only indication
of a lesion formed and it corresponded to a 64 W exposure for 1.1 seconds.
Figure 4.7(b) shows an example of a delayed response at the surface, which occurred in
two instances at low exposure and high duration. After 500 ms the change at the surface
started to shadow the focal point. This phenomenon originates from the appearance of
bubbles blocking ultrasound waves from propagating deeper into the tissue.
The remaining 14 lesions showed an almost immediate echogenic change at the skin-skull
interface, as seen in Figure 4.7(a), 4.7(c), 4.7(e) and 4.7(f). These figures also depict an
immediate reduction in the echo prominence beyond activity at the skull surface.
Upon completion of the lesion formation protocol, the skin surface of the rat skull was
examined for any visible damage. As seen in Figure 4.5, the rat exhibited a pronounced
amount of surface edema.
Histological evaluation of the rat brain did not reveal any of the lesions observed un-
der STF imaging. Based on the lack of damage seen upon histological examination,
it is necessary to reevaluate lesion formation protocol parameters, taking into account
the DMUA feedback. The echogenic change at the surface in 16 out of 17 cases, indi-
cated significant heat build up at the skull interface. The inability to observe echogenic
changes at the focal location 94 % of the time was consistent with the lack of histolog-
ical damage. A new protocol needs to minimize the skull heating, as it compromises
penetration of energy to the focus and also results in surface edema.
4.4 Conclusion
The feasibility of real-time image-guided placement and monitoring of tFUS beams using
dual-mode ultrasound arrays was demonstrated in an in vivo rat model. Synthetic
aperture imaging was used to guide the treatment procedure and identify important
anatomical landmarks, such as the outline of the skull and skin layer. Furthermore,
pulsating arteries within the field of view are often detectable on SA imaging. This is
significant since vessels are often the target of potential transcranial therapies.
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The results shown in this chapter have also demonstrated that real-time transcranial ul-
trasound thermography in vivo is capable of detecting and localizing the subtherapeutic
tFUS heating profile with high spatial and temporal resolution. During the application
of subtherapeutic tFUS patterns, with similar acoustic outputs, the heating rates esti-
mated in vivo were consistent with those measured ex vivo using thermocouples. Some
artifacts were observed on spatio-temporal temperature change profiles, but they neither
obscured the actual heating pattern nor limited our ability to localize the tissue response
to tFUS. Furthermore, STF-enabled monitoring revealed a significant amount of tissue
change at the surface during the lesion formation process ex vivo. After the completion
of treatment, surface edema was observed at the treatment site corroborating DMUA
feedback.
Chapter 5
Characterization of Transcranial
Focused Ultrasound Using
DMUA Applications: Ex Vivo
Studies
5.1 Introduction
Transcranial applications of focused ultrasound are often complicated by the presence
of the skull. Due to the high variability between the speed of sound in the tissue and
in the skull, the phase front emanating from the transducer becomes asynchronous and
results in a deformed focus. The research presented in this chapter was conducted
to characterize the degree of transcranial degradation of the DMUA focus. The char-
acterization consisted of two complementary experiments. The first experiment was
performed with two single-element transducers and allowed to estimate the amount
of energy transmitted through the rat skull and optimal transmission frequency. The
second experiment was conducted with a hydrophone and enabled visualization of the
DMUA focus distortion through the skull at two different frequencies.
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Figure 5.1: Experimental setup for the measurement of insertion loss through the skull.
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5.2 Methods
5.2.1 Measurement of Insertion Loss Through a Rat Skull
To characterize the insertion loss through the skull in the frequency range 1.8 - 4.1 MHz,
the setup shown in Figure 5.1 was used. Two single element transducers were placed in
a brass holder 1 inch apart and facing each other. The holder was secured to a 3-axis
servomotor. Each transducer had a center frequency of 3.65MHz ( 6dB bandwidth of
91.91%) and a focal length of 0.5 inches. The transducer facing the convex portion
of the skull was operated in transmit/receive (T/R) mode enabling the collection of
an echo waveform. The other transducer was operated in receive (R) only mode and
was used to compute the relative insertion loss between the bone and water travelling
paths.
The T/R and R transducers were connected to individual Panametrics pulser-receivers
(Olympus, Tokyo, Japan). The outputs of both pulser-receivers were connected to
an oscilloscope (Tektronix, Oregon, USA). The oscilloscope was setup to receive three
channels:
• Channel 1: the received signal from the T/R pulser-receiver
• Channel 2: the received signal from the R pulser-receiver
• Channel 3: the trigger signal from the T/R pulser-receiver
To prepare the skulls for the procedure, the skin was removed and the upper portion of
the cranium was separated with a bone band saw (Mar-Med Inc., Cleveland, OH, USA).
The skull was then immersed in a saline bath to remove particulates and afterwards fixed
in a 10% formalin solution. Fry and Barger [48] showed preserving the human skull in
the formalin solution affected insertion loss measurement by only 3dB on average.
To estimate insertion loss, the skull was rinsed in tap water and positioned in a tank
filled with degassed deionized water at a room temperature of 24◦C. The skull was then
scanned with an automated script written in MATLAB (MathWorks, Massachusetts,
USA). The spatial resolution in the lateral and elevation dimensions was set to 0.25
mm. At each spatial location, 50 waveforms were averaged on the oscilloscope for the
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T/R and R channels before being transferred to the PC via a GPIB interface. A delay
of 10 seconds between each spatial acquisition was introduced to allow for the motor
assembly to stabilize.
5.2.2 Data Analysis
The aforementioned experiment allowed the collection of two data sets: the topography
of the skull and two-dimensional insertion loss estimates. These variables were extracted
according to the following protocol:
• The topography of the skull was calculated based on the first arrival of the skull
echo in the T/R waveform.
• Insertion loss was estimated from the frequency spectrum of the R waveforms,
where the frequency spectrum of the reference waveform collected in water was
subtracted from the frequency spectrum of the waveform travelling through the
skull and water.
5.2.3 Hydrophone Characterization of a DMUA Focus
To characterize DMUA beam deformation through the skull, we conducted a hydrophone
study. The study was performed on a formalin-fixed skull, harvested from a 281 g
Sprague-Dawley female rat.
The first step of the characterization procedure was to map the pressure of a DMUA
field in water. The hydrophone was immersed in a water tank with degassed water,
and positioned with the guidance of SA imaging at the focal point of the DMUA. The
signal captured by the hydrophone was amplified with an AH-2010 preamplifier and
acquired by an oscilloscope with a sampling rate of 50 MHz (Tektronix, Oregon, USA).
The hydrophone was secured onto a 3-axis servomotor stage. After each change in
the hydrophone location, the DMUA system was programmed to emit a (120mV) 32
cycle burst with a center frequency of 3.2MHz and to transmit a trigger signal to the
oscilloscope. The oscilloscope transferred received waveforms to the PC via a GPIB
interface.
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To ensure the accurate acquisition of the DMUA pressure field, three scans were acquired
with the hydrophone:
1. First, a scan of the lateral-elevation plane starting at the approximate axial-lateral
DMUA focal center was used to find the lateral-elevation pressure maximum. To
locate the approximate axial-lateral DMUA focal center, SA imaging was used to
visualize the hydrophone tip positioned at the focal point. The DMUA focal field
was sampled in the lateral-elevation plane over a lateral range (-2.6mm to 2.6mm)
at 0.05 mm increments and an elevation range (-2.6mm to 2.6mm) with 0.1mm
increments with the motor speed set at 2 mm/s.
2. Second, a scan of the axial-lateral plane starting at the lateral-elevation maximum
was done to find the axial pressure maximum. The DMUA focal field was sam-
pled in the axial-lateral plane over an axial range (-7 mm to 7 mm) at 0.1 mm
increments and lateral range (-2.8 mm to 2.8 mm) with 0.05 mm increments. The
motor speed was reduced to 0.5 mm/s to ensure accurate signal capture at each
spatial location.
3. Third, a scan of the lateral-elevation plane was done starting at the determined
pressure maximum in the axial dimension. The DMUA focal field was sampled in
the lateral-elevation plane over a lateral range (-2.8 mm to 2.8 mm) at 0.05 mm
increments and an elevation range (-2.8mm to 2.8mm) with 0.1 mm increments
with the motor speed set at 0.5 mm/s.
After the acquisition of the DMUA pressure field in water, the skull was introduced
between the DMUA and the tip of the hydrophone as seen in Figure 5.2(a). Figure
5.2(b) depicts the approximate elevation location of the measurement through the skull.
As with the in vivo experimental setup, the axial placement of the skull was at 32 mm
on the SA image, such that the focal point was located 8 mm behind the bone. Three
different lateral configurations were tested: the midline, 2 mm to the left of the midline
and 2 mm to the right of the midline.
For each configuration, axial-lateral and elevation-lateral hydrophone scans were ac-
quired with the same protocol as described for water. The only difference was that
the axial scanning range was reduced to ensure the hydrophone tip did not touch the
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(a) Hydrophone facing the skull
(b) Skull positioned in front of DMUA
Figure 5.2: Experimental setup of the hydrophone scan of the DMUA focus through the
skull. The red line in (b) represents the center of the DMUA surface in the elevation
dimension.
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skull.
Characterization of the DMUA Focal Beam for Varying DMUA Frequen-
cies
We also investigated the pressure field profile as a function of different DMUA transmit
frequencies. For this experiment two frequencies (1.8 MHz and 3.2 MHz) were tested
with and without the skull. These hydrophone scans were acquired with the same
protocol as described for water.
5.3 Results
5.3.1 Insertion Loss Study
The goal of this study was to determine the insertion loss as a function of location and
frequency. The results of the insertion loss study were examined in a systematic manner,
starting with an inspection of the skull orientation with respect to the transducer. This
orientation was of significance, because the curvature of the skull affected how incident
waves were scattered at the skull. The skull surface geometry computed from the echo
waveforms for rats A and B is displayed in Figures 5.3(a). In both cases the orientation
of the skull was approximately symmetrical along the zero lateral parallel, allowing for
the investigation of insertion loss through the skull.
Next, we examined the amplitude spectra at different frequencies with and without the
skull. For a more complete picture of insertion loss through the skull, three unique
locations were chosen for examination:
1. (x1, y1) = (0 mm, 10 mm)
2. (x2, y2) = (0 mm, 15 mm)
3. (x3, y3) = (2 mm, 10 mm)
The resulting amplitude spectra for water and skull waveforms, as depicted in Figure
5.3(b), showed two notable features.
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• First, a significant reduction in amplitude spectra was observed for traces trans-
mitted through the skull with the trace at location (x2, y2) exhibiting the most
pronounced loss.
• Second, the pronounced frequency dependence of the amplitude was not consistent
between locations. For example, in the frequency range from 2.2 to 3.5 MHz, the
amplitude spectra behaved differently at the three locations, whereas below 2.2
MHz and above 3.5 MHz the amplitude spectra were strictly increasing and strictly
decreasing, respectively.
For a more thorough understanding of ultrasonic penetration, we examined the spatial
power loss results computed at three frequencies (1.8 MHz, 3.2 MHz, and 4.1 MHz). At
1.8 MHz the insertion loss was relatively consistent over the area of the skull as seen in
Figure 5.4(a). At the higher frequencies, 3.2 MHz (Figure 5.4(b)) and 4.1 MHz (Figure
5.4(c)), the insertion loss was more spatially dependent. These spatial dependencies
seemed to correlate with the gross anatomical features shown in Figure 5.5. In both
rats A and B, there was more insertion loss on the right side of the skull. A minor
deviation in orientation of the skull, nonuniform skull thickness, or an asymmetrical
cutting of the skull could explain this asymmetry.
5.3.2 Hydrophone Characterization of a DMUA Focus
To follow up on the results observed in vivo we conducted experiments to answer four
questions:
1. How does the skull affect the DMUA beam resolution?
2. How much power is lost due to the presence of the skull?
3. How are questions 1 & 2 affected by mechanical adjustments and electronic steer-
ing of the focus?
4. How are questions 1, 2, & 3 affected by changes in the DMUA frequency?
Subsequent sections are geared to answer these questions by scanning the DMUA field
with a hydrophone and examining its beam profile with and without the skull.
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(a) Skull topography for rats A and B
(b) Frequency spectrum of the transmitted pulse through water and three dif-
ferent locations in rat A skull
Figure 5.3: Topography maps of the skulls from rats A and B are depicted in (a), and
the frequency spectra of the transmitted pulses are depicted in (b).
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(a) 1.8 MHz
(b) 3.2 MHz
(c) 4.1 MHz
Figure 5.4: Insertion loss in dB measured at three frequencies (1.8 MHz, 3.2 MHz, and
4.1 MHz) for two rats (A and B).
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(a) Rat A
(b) Rat B
Figure 5.5: Inferior view of the upper portion of the skulls from rats A and B.
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Beam Resolution with and without the Skull
Hydrophone scans were conducted to visualize axial-lateral and elevation-lateral cross-
sections of the DMUA beam in the water, with and without the skull. At the start of
the data acquisition, the hydrophone was first localized on the SA image. Figure 5.6(a)
depicts the tip of the hydrophone at the (x, z) = (0 mm, 40 mm) location inside the
water. When the skull was positioned in front of the DMUA, the hydrophone tip could
still be visualized (see Figure 5.6(b)); however, the original resolution was degraded.
This observation was consistent with our previous results from the wire phantom study,
presented in section 3.3.2.
Figures 5.7(a) and 5.7(b) depict axial-lateral beam profiles in water and through the
skull. The skull resulted in a spreading of the beam energy and reduced the focal gain
revealing pre-focal sidelobes. The deformation of the focused beam was noticeable both
the in axial and lateral dimensions when the skull was introduced (see Table 5.11 ).
This observation is in line with previously documented temperature profiles in vivo,
where the heating was often observed 2 mm proximal to the target.
Power Loss Through the Skull
An accurate estimate of the power loss due to the reflection and absorption of the skull
is necessary to estimate how much power can be gained through refocusing. To estimate
power loss, the intensity was integrated over the elevation-lateral plane (-2.5 mm to 2.5
mm in both dimensions) both with and without the skull. The difference between the
power with the skull and the power without the skull was 6.8 dB and represented the
power lost due to reflection and absorption.
Furthermore, we examined maximum intensity values with and without the skull to see
if the difference in these values were comparable to the power loss estimates. By com-
paring the maximum intensity with and without the skull we observed a difference of
9.1 dB. As we already determined that only 6.8 dB of this loss was due to reflection and
absorption, optimally 2.3 dB of intensity could be gained through refocusing. Since the
1 Lateral and elevation resolution values were not corrected for the effect of the finite size of the
hydrophone.
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(a) SA image without the skull (55dB)
(b) SA image with the skull (55dB)
Figure 5.6: SA images of the hydrophone tip without (a) and with the skull (b) in water.
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(a) Axial-lateral profile w/o skull (b) Axial-lateral profile w/ skull
(c) Elevation-lateral profile w/o skull (d) Elevation-lateral profile w/ skull
Figure 5.7: DMUA normalized intensity profiles with and without the skull.
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maximum intensity is directly proportional to the heating rate at the focus, improve-
ments in the focal intensity would allow a minimization of both the pre-focal heating
and the acoustic power necessary to cause a desired change during subtherapeutic and
therapeutic exposures.
Mechanical Adjustment vs Electronic Steering of the DMUA beam
Up until now the hydrophone scans were performed by aligning the midline of the
skull symmetrically with the DMUA surface. In this section we investigate the effect
of either electronically steering the beam or mechanically positioning it ± 2 mm off
the midline. Figures 5.8(a) and 5.8(b) depict the results of DMUA beam electronic
steering, whereas Figures 5.8(c) and 5.8(d) represent the mechanical movement of the
skull in respect to the DMUA focus. The beam profiles with mechanical adjustment and
electronic steering were spatially similar to each other, such that the imprecision of the
mechanical movement could explain all of the deviation (mechanical displacement was
precise within 1 mm). This spatial similarity and imprecision of mechanical adjustment
suggests that electronic steering could be advantageous, particularly because it requires
less time, keeps the same configuration between probe and the targeted organ, and is
more spatially precise. However, a comparison of the resolution and power levels between
mechanical adjustment and electronic steering (see Table 5.1) provided contradicting
resolution and power loss results. Because this is a small data set, the results presented
here should be used as a guide to further investigation.
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Table 5.1: DMUA beam resolution without and with the skull
DMUA Focus Water/ Axial Lateral Elevation Acoustic Power
Freq. [Ax; Lat.] Skull DoF Resol. Resol. Intensity
(MHz) (mm) (mm) (mm) (mm) (W/cm2) (W)
1.8 [40; 0] Water 4.537 0.850 1.237 4.538 198
3.2 [40; 0] Water 2.962 0.487 0.712 217.143 3492
4.1 [40; 0] Water 2.375 0.393 0.571 83.870 875
1.8 [40; 0] Skull 5.312 0.829 1.238 0.953 41
1.8 [40; -2] Skull > 8 1.253 1.459 0.352 31
1.8 [40; 2] Skull 4.927 1.107 1.450 0.480 36
3.2 [40; 0] Skull 3.106 0.483 0.825 26.688 717
3.2 [40; -2] Skull 4.543 0.661 0.927 17.516 607
3.2 M [40; -2] Skull 5.539 0.653 0.904 19.265 606
3.2 [40; 2] Skull 5.094 0.608 1.440 16.832 736
3.2 M [40; 2] Skull 3.883 0.854 0.815 19.393 691
DMUA Transmit Frequency: 1.8MHz vs 3.2MHz
The final point of investigation was frequency choice for the transcranial experiments.
First, we examined the DMUA focal resolution at the midline location for the two
frequencies, as depicted in Figures 5.9(c) and 5.9(d). It is evident that at 1.8 MHz
the beam is more localized, and the prefocal sidelobes are less pronounced. However,
the use of the refocusing algorithm at 3.2 MHz could potentially restore its superior
resolution.
Electronic steering the beam to ± 2 mm changed the profile of the beam significantly
for both frequencies, as seen in Figure 5.10. In Figure 5.10(b) the axial resolution of
the beam at 1.8 MHz exceeds 8 mm, which is almost the length of the skull (≈ 10 mm)
cross-section. Using a frequency which produces a small interrogation location, reduces
the risk of standing waves in the skull and helps achieve a more targeted therapy. As a
result, 1.8 MHz was not an optimal choice for localized transcranial applications.
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(a) Electronically refocused (-2mm) (b) Electronically refocused (2mm)
(c) Mechanically moved (-2mm) (d) Mechanically moved (2mm)
Figure 5.8: Hydrophone scans of DMUA focus through a skull of a Sprague-Dawley
rat. Electronic refocusing is compared to a mechanical translation of the skull to a new
location.
66
(a) W/o skull at 3.2 MHz (b) W/o skull at 1.8 MHz
(c) With the skull at 3.2 MHz (d) With the skull at 1.8 MHz
Figure 5.9: DMUA Focus with and without the skull at two different frequencies (1.8
MHz and 3.2 MHz).
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(a) 3.2 MHz (b) 1.8 MHz
(c) 3.2 MHz (d) 1.8 MHz
Figure 5.10: DMUA focus steered ±2 mm of the midline at two different frequencies
(1.8 MHz and 3.2 MHz).
68
At last, we compared the power loss at 1.8 MHz with and without the skull in water.
The value of the power loss was equal to 6.8 dB, and was in close agreement with the
value previously computed for 3.2 MHz.
Conclusion
In this chapter we examined insertion loss through the rat skull and observed the vari-
ability of the estimate both in space and as a function of frequency. The frequency of
3.2MHz was validated as appropriate for maintaining focus and avoiding interference
patterns from the back of the skull. Additionally, we have learnt that different loca-
tions exhibit different focal distortions. The degree of distortion was less pronounced
when the skull was symmetrically aligned with the DMUA. Electronic steering of tran-
scranial focused ultrasound beams does not appear to produce more distortions than
mechanical adjustment of the focus. Presented results confirm that although the skull
introduces a measurable distortion, the focus is still localized, enabling the measurement
of transcranial FUS-tissue interactions with the DMUA.
Chapter 6
Localized Assessment of
HIFU-induced Changes in Tissue
Properties
6.1 Introduction
As the notion of focused ultrasound (FUS) as a noninvasive alternative to conventional
surgery is becoming more widely accepted, the need for reliable quantitative feedback
to assess thermal damage is growing. The dual-mode ultrasound array was designed
to form a highly localized heating spot. When this functionality is combined with the
ultrasound thermography the operator gains the ability to make a localized noninvasive
measurement at a subtherapeutic exposure level.
In this study we expand on previous research in [39], by estimating the initial heating
rate before and after therapeutic lesion formation through the delivery of a subthera-
peutic intensity shot in ex vivo bovine heart tissue and an in vivo rat. Careful gross
examination of the tissue confirms the measurement for every location where quantita-
tive estimates were taken.
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6.2 Methods
6.2.1 System Description
Subtherapeutic and therapeutic shot delivery and imaging were enabled by a custom
designed platform with a 3.5 MHz DMUA (Imasonic, Besancon, France). The experi-
ments were conducted in a water tank with the DMUA attached to one side facing a
piece of tissue in a rubber holder as shown in Figure 6.1b. Precise movement of the
tissue block was enabled by a motorized stage. Both the tissue and water were kept at
room temperature. During shot delivery STF images were collected at 140 fps. STF-
based thermography enabled the estimation of the temperature profile used to extract
the initial heating rate.
6.2.2 Absorption Measurement
The method use to determine the rate-of-heating, shown in [49], was derived from the
Pennes bioheat transfer equation (6.1).
ρtCt
∂T
∂t
= kt∇2T − wbCb(T − T∞) + 2αI (6.1)
where ρt is tissue density, Ct the specific heat of the tissue, T the tissue temperature,
t time, kt the thermal conductivity of the tissue, wb the blood perfusion rate, Cb the
specific heat of blood, Ta the arterial blood temperature, α the absorption coefficient of
the tissue, and I the local ultrasonic intensity.
When the initial heating rate measurement is done shortly after the start of therapy,
tissue diffusion and perfusion are negligible. This allows for the simplified version of
the Pennes bioheat equation as seen in equation 6.2. This equation includes an initial
heating rate proportional to the local ultrasonic intensity, as well as the tissue density,
specific heat and absorption coefficient.
dT
dt
≈ 2αI
ρtCt
(6.2)
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Figure 6.1: The DMUA is submerged inside a water tank facing a piece of bovine heart
tissue.
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To estimate the appropriate power levels for the subtherapeutic shot delivery, we first
determined the relationship between voltages and the power output using an ultrasound
power meter (Ohmic Instruments, Easton, MD). Additional calibration was conducted
in bovine heart tissue with a 200 µm T-type copper-constantan thermocouple (Omega,
Stamford, CT). After the calibration, a set of 1 second subtherapeutic shots was deliv-
ered 12 mm deep in the bovine heart tissue. The set contained five distinct acoustic
intensities: 140 W/cm2, 250 W/cm2, 390 W/cm2, 560 W/cm2, and 760 W/cm2. These
subtherapeutic shots were repeated twice, first in increasing intensity levels (140 W/cm2,
250 W/cm2, etc.) and second, in decreasing intensity levels (760 W/cm2, 560 W/cm2,
etc.) prior to lesion formation. After subtheraputic shots, volumetric lesion was formed
using electronic steering with the DMUA. In tissue block # 1, the volumetric lesion was
composed of 5 electronically steered foci spaced .55 mm apart (1350 mW/cm2), with
each shot ON for 200ms at a location before rotating to the next location, for a total
duration of 5 seconds (Figure 6.2a). After the completion of therapy, the subtherapeutic
shots were repeated. In tissue block #2, lesion parameters were the same, except the
foci were spaced 0.50 mm apart (Figures 6.2b and b1).
Once the temperature data was extracted, the initial heating rate estimates were com-
puted for the first 300 ms after the start of subtherapeutic exposure. The temperature
probing location was chosen by finding the maximum temperature increase along the
lateral axis within +/- 3 mm of the geometric focus in the axial dimension.
6.2.3 Noninvasive IgFUS with the In Vivo Small-animal Model
Trackless lesion formation was performed in the hind limb of Copenhagen rats in accor-
dance with approved protocol (UMN IACUC #1101A94814) and UST was performed
using the DMUA and SonixRP integrated system (section 2.1). A 3.5 MHz concave
transducer array (40-mm radius of curvature) was used to generate FUS beams with di-
mensions of 0.2×0.4×2mm3 in the lateral, elevation, and axial dimensions, respectively.
The therapy array has a fenestration that allowed for the use of a diagnostic probe for
real-time imaging of the tissue with the imaging slice aligned with the FUS beam in the
lateral and axial directions. The animal was placed in a temperature-controlled water
bath with its hind limb positioned so that the focal spot of the therapy array was 6 -
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Figure 6.2: Gross images of lesions formed in Block # 1 (a) and Block # 2 (b). These
images capture tissue cross-sections in the lateral-elevation plane with respect to the
transducer beam axis.
Figure 6.3: The temperature collected during subtherapeutic shots acquired at 760
mW/cm2 before (a) and after (b) therapy, with the red line depicting the capture
location of the temperature traces plotted in (c). In (c) the dotted lines represent the
measurements made before therapy, and the solid lines represent measurements made
after therapy.
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10 mm under the skin.
A typical lesion formation procedure involved the use of two subtherapeutic FUS beams
before and after the therapeutic beam, all with the same duration but differing in
intensity. The subtherapeutic beam intensity was chosen to produce a 1 - 3◦C change
at the intended lesion location. Two discrete lesions were formed in one or more planes
before the animal was removed from the water bath and allowed to recover for 4 hours
before sacrifice. After sacrifice, the rat was perfused intracardially with 120 ml of saline,
190 ml of nitro blue tetrazolium (NBT) and 120 ml of 10% formalin. The formalin-fixed
right leg was scanned using two modalities: a SonixRP US scanner with an L14-5/38
probe and a 9.4 Tesla MRI with a voxel size of 0.14× 0.14× 0.27mm3. For the 3D scan
with SonixRP, the probe was positioned on a Vexta stepping motor (PK266-03A-P1).
The fixed tissue was then sliced at ≈ 3 mm intervals, photographed and submitted for
further histological processing.
6.2.4 UST and Tissue Property Measurement
Real-time UST images were formed using the system described in section 2.1. Briefly,
beamformed RF data from a limited frame around the heated region (referred to as
M2D data) was obtained using the diagnostic probe connected to the Sonix RP scanner.
M2D-mode imaging allowed for the use of frame rates in the range of 80 - 500 fps, which
proved suitable for capturing the full dynamics of tissue motion and deformation using
speckle tracking techniques as described in [42] and references thereof. For the current
experiment, M2D frames were acquired at 91 fps which allowed for the capture of the
pulsation of blood vessels near the lesion as well as other movements, e.g. animal gasps
due to deep anesthesia. Speckle tracking and subsequent 2D filtering of echo shift data
were used to compute estimates of temperature change over every pixel of the M2D
frame on an a grid with spacing 18.75 × 200µm2 in the axial and lateral dimensions
and with a 1/91 sec time step. This fine spatial and temporal resolution allowed for the
computation of both temporal and spatial derivatives without noise amplification. For
example, the initial heating rate (IHR) was computed over every pixel of the M2D frame
as a function of time. In conjunction with subtherapeutic FUS beams, peak of the IHR
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occurred approximately at the focal location with values depending on the intensity of
the beam and local absorption.
6.2.5 Image Registration
Three-step Registration Based on 3D US/MRI Images
The quality of real-time US imaging was too poor to allow for reliable registration of
gross histology and led to unsatisfactory results (using CPD and other methods). This
was primarily due to the difficulty of identifying landmarks on the US images to guide
the deformation procedure. However, it is well known that 3D US, especially in C-mode,
provides significantly improved feature detection. Furthermore, the superior soft tissue
contrast provided by 3D MRI can help further refine the feature detection process. This
3-step registration process combined 3D data from both modalities as depicted in Figure
6.4.
The first step involved the alignment of two fixed tissue volumes using 3D US and 3D
MRI. The US volume was normalized to match the voxel dimensions of the MRI volume.
Next the upper surface boundary of the rat leg was extracted from both the MRI and US
fixed volumes. The registration was done using the CPD algorithm, described in [50].
Approximately 4000 points were extracted from both volumes, and because of these large
point sets the fast Gauss transform was used during the registration. The alignment
between US and MRI volumes was assumed to be affine due to the fixed nature of
the tissue. The final volume correspondence was examined, and any additional volume
transformations were done manually.
The second step involved manual localization of the 2D gross cross-section within the
MRI volume (slice to volume registration). This was performed manually using clear
features, e.g. bone, connective tissue and fat. This step resulted in an MRI-equivalent
of the gross cross section.
The third step relied on steps 1 and 2, which revealed landmarks seen both on the
real-time US and the gross cross-section. During this step the in vivo US image was
aligned with the gross image based on a nonrigid point set registration.
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Figure 6.4: A flow diagram of the image registration algorithm.
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CPD Algorithm Summary
The CPD algorithm described in [50] provided a robust registration tool for both 3D
and 2D data sets and gave considerable insight which was key, especially given the
nature of US imaging. In this algorithm, the matching of two point sets was modeled
as a probability density estimation problem. The first point set, the Gaussian Mixture
Model (GMM) centroids, was aligned with the second point set, also known as the
data points. This alignment was done through the expectation maximization (EM)
algorithm. The key feature of this algorithm is the motion coherence constraint, which,
when imposed onto the velocity field, preserves the topological orientation of the point
sets. For our problem, we found the CPD to be quite useful in both the 3D US-MRI
registration and the 2D US-Gross registration. The algorithm was largely the same for
both cases, except for the use of the transformation operator, which was affine for the
3D case and nonrigid for the 2D case. Reference [50] provides an excellent description
of the algorithm for the interested reader.
6.3 Results and Discussion
The results of lesion formation in tissue Block # 1 are summarized in Figure 6.2a, where
five volumetric lesions (L1-L5) are seen with each lesion comprising five individual foci.
In Figure 6.2b and 6.2b1 gross lesions within Block # 2 are captured, and labeled L1
through L8. During gross inspection the volumetric lesions in Block # 2 appear more
homogeneous. It is hypothesized that decreasing inter-foci spacing from 0.55mm to
0.50 mm sustained the more coherent temperature distribution needed for a continuous
volumetric lesion.
Once lesions were localized and inspected, the axial-temporal profile for each lesion
was analyzed. Figure 6.3 illustrates spatial-temporal temperature maps at 760 W/cm2
intensity before (a) and after (b) lesion formation. Individual traces for five acous-
tic intensities are seen in Figure 6.3c. Pronounced temperature increases and heating
rates were observed after therapy for the majority of lesions in Block # 1. Also, close
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Figure 6.5: Statistics summary for (a) tissue Block # 1 for locations L1 through L5,
and (b) tissue Block # 2 for locations L1, L6, L7 and L8.
Table 6.1: Summary of Initial Heating Rates Pre and Post Therapeutic Lesion Forma-
tion.
Io(W/cm
2) H p Median (PRE) Median (POST) Difference
140 0 0.21360 0.38 0.41 10%
Tissue 250 1 0.00054 0.70 0.84 20%
Block #1 390 1 0.00001 1.18 1.35 15%
560 1 0.00002 1.75 2.07 18%
760 1 0.00002 2.46 2.84 16%
Io(W/cm
2) H p Median (PRE) Median (POST) Difference
140 0 0.96000 0.34 0.34 2%
Tissue 250 0 0.92330 0.67 0.67 0%
Block #2 390 0 0.70420 1.14 1.23 7%
560 1 0.00540 1.67 1.87 11%
760 1 0.04510 2.46 2.58 5%
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agreement between the temperature profiles acquired during subtherapeutic shots de-
livered prior to therapy in increasing intensities and decreasing intensities, established
the repeatability of the measurement. This ensured that the tissue was not thermally
modified as a result of the measurement.
The initial heating rate measurements for all subtherapeutic shots before and after
therapy delivery are summarized in scatter plots in Figures 6.5a and b. A statistical
summary of these measurements appears in Table 6.1. As seen from the table, the
null hypothesis was supported for the lowest exposure (140 W/cm2). However, for the
remainder of the subtherapeutic exposure groups the null hypothesis was rejected with
p ≤ 0.01.
In tissue Block # 2, a strong degree of change in the initial heating rate was observed at
locations L2, L3, and L5. The lesions formed at locations L1, L6, L7, and L8 exhibited
only a small change in the initial heating rate. These four lesions are depicted on the
graph in Figure 6.5b. When performing the Student’s t-test for each subtherapeutic
exposure group before and after therapy, no pronounced difference was observed for
the three lowest exposures (140 W/cm2, 250 W/cm2, 390 W/cm2). The highest two
exposures, 560 W/cm2 (p ≤ 0.01) and 760 W/cm2 (p ≤ 0.05), exhibited a pronounced
difference in the heating rate before and after therapy. Also, upon gross examination
these four locations corresponded to lesions lighter in color than the lesions at loca-
tions L2 and L3 (L5 was excluded from comparison due to the presence of connective
tissue).
In addition to a documented increase in the heating rate for the post therapy mea-
surements, a higher temperature rise following therapy was observed spatially on an
axial-temporal slice for all block # 1 lesions and block # 2 lesions L2, L3, and L5.
6.3.1 Noninvasive IgFUS In Vivo Small-animal Model
Figure 6.6 shows a representative cross-section through the rat thigh, where 6.6(a) is
the reference MRI volume, 6.6(b) is the unregistered US volume and 6.6(c) is the 3D ul-
trasound volume that was registered with the affine CPD algorithm. On the ultrasound
cross-section, specular structures can be visualized surrounding the boundary of the rat
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leg. These are bubbles of air trapped within unshaven skin regions. From the images
we can also identify a connective tissue triangle, appearing black on the right side of
the MRI cross-section. This same triangle appears hyperechoic on the US image.
After taking these images, we localized the therapeutic plane within the 3D MRI volume.
In Figure 6.7(a) the representative cross-section through the therapeutic plane is seen,
with both formed HIFU lesions outlined by white rectangles. The gross image seen in
Figure 6.7(a) was used as a sliding reference to identify the corresponding treatment
plane within the MRI volume. For localization, unique traits were identified, including:
two bones (tibia and fibula), a connective tissue triangle with a blood vessel running
through it, and visible separation boundaries between different muscles. With the help
of these traits, the corresponding MRI cross-section was identified (Figure 6.7(b)), and
the bones and skin periphery were outlined by a blue line.
The presence of a therapeutic cross-section in two different modalities (MRI and US)
in addition to a gross image allowed us to identify control points to register the in vivo
US B-mode image with the gross image. Within the in vivo ultrasound image seen in
Figure 6.8(a) the control points used for the registration are outlined. They include the
skin periphery and connective tissue layers that were confirmed through the alignment
of 3D MRI and 3D US volumes. Additional control points were extracted from the
strain data representing microvessels with a diameter between 60 and 100 µm as seen
on the histology slides. After the manual placement of control points was complete, they
were fed into the nonrigid CPD algorithm. Final alignment of the MRI and ultrasound
volumes is seen in Figure 6.8(c), where the blue points are the transformed point set
and the red points are the reference point set. The acquired transformation matrix was
then applied onto the 2D gross image, with the resultant transformation seen in Figure
6.8(d).
The final step of the process was to overlay the tissue parameters extracted from the
M2D onto the registered gross image. Since the M2D window was inherently aligned
with the in vivo US B-mode image, no additional deformations were needed to register
the gross image with the M2D image. The overlay of the heating rate extracted from the
ultrasound temperature data before lesion formation is visualized overlaying the gross
image in Figure 6.9(b) and after lesion formation in Figure 6.9(c). The results clearly
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(a) Reference MRI (b) Initial US (c) Aligned US
Figure 6.6: Representative cross-sections from 3D MRI/US data.
(a) Gross Image (b) MRI Cross-section
Figure 6.7: Therapeutic plane cross-section visualized on registered MRI and gross
image cross-sections. White boxes outline two lesions formed at the time of therapy.
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(a) Reference US Image (b) Gross Image
(c) Point Sets Aligned (d) Transformed Image
Figure 6.8: In vivo US image (a) with the corresponding control points depicted in
red, to be co-registered with the gross image depicted in (b). For (a) and (b) yellow
circles represent control points associated with the microvessels. The result of the regis-
tered points sets through Nonrigid CPD algorithm is depicted in (c), the corresponding
transformed image (d).
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(a) Gross Image (b) Pre-therapy (c) Post-therapy
Figure 6.9: Heating rate projected onto the gross image (a), before (b) and after (c)
therapy.
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show: 1) the correspondence between the high IHR and the target lesion location,
and 2) the increase in size of the IHR after lesion formation, indicating a change in
absorption.
Even in the small animal rodent model used to obtain the results presented in this
chapter, it is seen that motion and tissue deformations are significant enough to call
for correction using robust registration algorithms. Our initial effort to associate sub-
surface landmarks from the real-time 2D ultrasound with anatomical features on gross
histology produced mixed results. The incorporation of 3D imaging data, both MRI
and US, allowed for reliable landmark identification with improved localization.
The quality of the real-time ultrasound imaging used in these experiments was com-
promised to some extent by the water coupling which increased reverberations and
reduced contrast. Despite these limitations, the quality of the registration allowed for
the mapping of the UST-based quantitative (spatial) measurements onto the actual
lesion location.
6.4 Conclusion
We have shown that subtherapeutic shot delivery combined with DMUA imaging, en-
abled estimation of a localized heating rate indicative of tissue damage. Real-time
guidance and the monitoring of therapeutic HIFU beams with DMUA, make ultra-
sound thermography a powerful tool that will help FUS surgery reach its potential as a
safe and effective noninvasive treatment for a variety of diseases.
Chapter 7
Conclusions and Future Work
The work presented in this thesis focused on the use of ultrasound thermography as an
image-guidance approach to visualize FUS-tissue (thermal) interactions. This evalua-
tion was performed using two systems, 1) DMUA only and 2) DMUA integrated with a
diagnostic ultrasound scanner. Both systems successfully demonstrated the advantages
of using thermography in conjunction with the subtherapeutic FUS delivery. These ad-
vantages include localization of the beam, treatment planning and damage assessment
following lesion formation.
In Chapters 3 and 4, we demonstrated the feasibility of real-time image-guided place-
ment and monitoring of transcranial focused ultrasound (tFUS) beams using DMUAs
in a rat model. Synthetic aperture (SA) DMUA imaging was shown to reliably capture
key anatomical features delineating the scalp, the skull and the base of the skull. Fur-
thermore, pulsating arteries within the imaging field of view are often detectable on SA
imaging. This is significant since vessels are often the target of potential transcranial
therapies. We have also demonstrated that real-time transcranial ultrasound thermog-
raphy in vivo is capable of detecting and localizing the subtherapeutic transcranial FUS
heating profile with high spatial and temporal resolution. The heating rates estimated
in vivo were consistent with those measured ex vivo using thermocouples during the
application of subtherapeutic tFUS patterns with similar acoustic power outputs. Some
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artifacts were observed on spatio-temporal temperature change profiles, but they nei-
ther obscured the actual heating pattern, nor limited our ability to localize the tissue
response to tFUS.
A thorough characterization of DMUA imaging and therapy through the skull was
performed in Chapter 5. Mapping the DMUA field with a hydrophone allowed the
confirmation of a localized profile of the DMUA focus through the mid-section of skull
at 3.2 MHz. Furthermore, an insertion loss study revealed both spatial and frequency
dependence of the energy loss through the skull. These preliminary findings are likely to
be further strengthened by the application of planned adaptive refocusing for improved
transcranial imaging and therapy with DMUAs. Not only will the DMUA approach
provide a means to guide the placement of tFUS beams, but it will also provide highly
specific imaging characterizing the tFUS-tissue interactions. This could be the key to
a better understanding of the mechanisms at play in major applications like neuro-
modulation, the blood-brain barrier opening, and an enhanced delivery of therapeutic
agents.
In Chapter 6, we propose a subtherapeutic shot delivery protocol to measure changes in
tissue properties due to HIFU lesion formation both ex vivo and in vivo. This protocol
was validated both through gross tissue and histological examination. The heating rate
measurements taken ex vivo revealed that sub-therapeutic imaging could be used as a
quantitative tool for tissue damage assessment. Furthermore, in vivo results conducted
in the hind limb of a rat further were in line with the ex vivo findings.
Focused ultrasound is becoming more widely accepted in the clinic in a variety of appli-
cations. However, there is still an urgent need for more quantitative guidance method
with high specificity to FUS-tissue interactions. The ability to register real-time US
to the histology/gross pathology is an important step towards the validation of tissue
property measurements based on ultrasound thermometry. The measured tissue param-
eters can be directly correlated to different zones of damage seen on histology. This is
a key step towards the use of ultrasound thermography data as a tool to predict and
quantify tissue damage after HIFU treatment. The ability to analyze and potentially
predict different types of damage based on the temperature maps will enable physicians
to target specific tissues with a high degree of confidence. The high temporal and spatial
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resolution of ultrasound thermography has the potential to improve both the safety and
efficacy of noninvasive ultrasound guided HIFU.
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Appendix A
DMUA Characterization
A.1 DMUA Power Charcaterization
A.1.1 Methods
To estimate the power output of the DMUA, ultrasound power was measured with an
Ultrasound Power Meter (Model UPM-DT 100AV, Ohmic Instruments Inc., Easton,
MD, USA). The power meter was filled with degassed deionized water (24◦C) and
positioned under a motorized stage to which a 3.5 MHz DMUA was secured (as seen in
Figure A.1). The array was first cleaned with an antiseptic alcohol wipe towelette and
then encapsulated inside a water bolus, filled with degassed water (24◦C). The bolus
was incorporated to simulate in vivo experimental conditions.
To ensure accurate power measurement, the geometric focal point of the array was
aligned with the 45◦ conical target of the ultrasound power meter. SA imaging provided
visual feedback for accurate positioning of the ultrasound transducer and enabled post
measurement monitoring for potential disturbances of the cone. On the SA image the
cone tip was positioned at 39 mm, allowing the cone to intercept the focal beam of
the transducer. Imaging feedback also confirmed a lack of mechanical vibrations in
the environment. After the two systems were aligned, the cone of the power balance
was calibrated with a 1gr = 14.5 W weight. Next a set of subtherapeutic voltages was
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Figure A.1: DMUA positioned for ultrasonuic power measurement. The ultrasound
power meter used for the measurement was manufactured by Ohmic Instruments Co.
(Model UPM-DT-100AV, Easton, MD, USA)
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calibrated, from 50 mV to 425 mV, with a step size of 25 mV. For each voltage the
DMUA delivered power for a period of 3sec and the measurement was repeated three
times.
Results
Figure A.2 summarizes the power measured for voltages between 50 mV and 425 mV.
The numerical averages of the power levels over the three trials were also listed in
Table A.1 and A.2. A linear relationship between squared voltages and the power was
observed up until 425 mV; the equation y = 10−5x was obtained by fitting points
between 50 mV and 300 mV and setting the intercept to zero. This equation allows
the estimation of intermediate power values for subtherapeutic exposures, assuming a
linear dependence for the subtherapeutic exposures.
A.2 DMUA Beam Profile Characterization
A.2.1 Hydrophone Scans
Methods
The measurement of the pressure field for a fenestrated DMUA transducer was collected
with the 0.2mm Onda hydrophone. The hydrophone signal was amplified with a AH-
2010 preamplifier, and transmitted through a coaxial cable to the Tektronix oscilloscope
(model TDS5104B, Beaverton, OR, USA). To acquire a spatial pressure map, the DMUA
transmitted a 10 µs pulse at 3.2MHz each time a 3-axis stage motor (Quicksilver Controls
Inc., Covina, CA, USA) moved to a new location. Each transition triggered the scope
enabling an accurate capture of the signal.
For each spatial location of the hydrophone a raw trace from the oscilloscope was trans-
ferred through a GPIB interface (16-bit DAQ on the Oscilloscope) to the PC and stored.
In the axial-lateral scan the spacing was 250µm in axial and lateral dimensions. In the
elevation-lateral scan the spacing was 125µm in elevation and lateral dimensions.
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Figure A.2: Ultrasonic power measurements as measured by the power meter for a range
of voltages between 50 mV and 550 mV.
Table A.1: Ultrasonic Power Values Summarized for a Range of Subtheraputic Voltages
Voltage (mV) 50 75 100 125 150 175 200 225 250 275
Power (W) 0 0.5 1.0 1.5 2.0 3.0 4.0 5.0 6.3 7.4
Table A.2: Ultrasonic Power Values Summarized for Voltages above 300mV
Voltage (mV) 300 325 350 375 400 425 450 475 500 525 550
Power (W) 8.5 9.9 11.6 13.0 14.5 15.9 19.2 24.2 27.7 29.5 30.8
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The intensity maps were constructed in MATLAB (MathWorks, Natick, MA, USA).
Each trace was detrended, filtered with a band-pass filter, and the RMS of the sinusoidal
signal acquired for each pixel producing a 2D map representative of the pressure profile
of the array. Next the intensity was computed by squaring the pressure equivalent and
normalizing the maximum to one W/cm2. The spline interpolation was applied to the
final 2D map to achieve 0.041 mm spacing between each pixel.
Results
Figure A.3 depicts the resulting normalized intensity profile for a 3.5MHz DMUA. In the
axial-lateral plane (Figure A.3(a)) the focus was asymmetrical due to several dysfunc-
tional array channels. In the lateral-elevation plane (Figure A.3(b)) three pronounced
foci are seen at: (0 mm, -1 mm), (0 mm, 0 mm) and (0 mm, +1 mm). The resolution
values are summarized in Table A.3.
Table A.3: Beam Resolution for a 3.5MHz Fenestrated DMUA
FWHM Fenestrated DMUA (S/N 8660, A102)
Axial (mm) 2.440
Lateral (mm) 0.473
Elevation (mm) 0.443
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(a) Axial-Lateral Normalized Intensity
(b) Lateral-Elevation Normalized Intensity
Figure A.3: Hydrophone Scans for 3.5MHz Fenestrated DMUA (S/N 8660, A102)
Appendix B
Acronyms
Table B.1: Acronyms
Acronym Meaning
DMUA Dual-Mode Ultrasound Array
FUS Focused Ultrasound
HIFU High-Intensity Focused Ultrasound
IHR Initial Heating Rate
MRIgFUS Magnetic Resonance Imaging-guided Focused Ultrasound
SA Synthetic Aperture
STF Single Transmit Focus
tFUS Transcranial Focused Ultrasound
USgFUS Ultrasound-guided Focused Ultrasound
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